<DOC>
	<DOCNO>NCT00382460</DOCNO>
	<brief_summary>The primary purpose study evaluate 4000 subject acute coronary syndrome compare pravastatin 40 mg atorvastatin 80 mg determine clinically equivalent , evaluate effectiveness gatifloxacin therapy reduce cardiovascular event combination statin therapy .</brief_summary>
	<brief_title>Pravastatin Atorvastatin Evaluation Infection Therapy ( TIMI22 )</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Hospitalization MI high risk unstable angina within last 10 day . Total cholesterol 240 mg/dl great . Stabilized post ACS Comorbidity life expectation 2 year . Current lipid lowering therapy Corrected QT interval Need Class IA III antiarrhythmic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>